Chou C-K, A Guy, LL Kunz, RB Johnson, JJ Crowley and J. H
Authors not listed · 1992
View Original AbstractCancer research reveals how immune regulatory cells create therapeutic challenges, providing context for understanding EMF's potential immune system impacts.
Plain English Summary
This 2020 review study examined regulatory T cells (Tregs) in cancer environments, focusing on how these immune cells suppress the body's natural cancer-fighting responses. The researchers analyzed various molecular pathways and receptors that control Treg function and evaluated potential therapeutic strategies. The findings highlight the challenge of targeting these cells for cancer treatment without compromising the immune system's normal protective functions.
Why This Matters
While this cancer immunology research doesn't directly address EMF exposure, it provides crucial context for understanding how electromagnetic fields might influence immune function and cancer development. The study's focus on regulatory T cells is particularly relevant because these immune cells play a dual role - they prevent autoimmune diseases but also help tumors evade immune detection. Several EMF studies have suggested that radiofrequency radiation can alter immune cell behavior and potentially suppress natural tumor surveillance mechanisms. The complex balance between immune tolerance and cancer protection that this research describes becomes especially important when considering how chronic EMF exposure might tip that balance in favor of tumor growth.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{chou_c_k_a_guy_ll_kunz_rb_johnson_jj_crowley_and_j_h_ce4874,
author = {Unknown},
title = {Chou C-K, A Guy, LL Kunz, RB Johnson, JJ Crowley and J. H},
year = {1992},
doi = {10.1186/s12943-020-01234-1},
url = {http://www.saferemr.com/2016/06/national-toxicology-program-not-first.html},
}